I. Benhar

发表

Killing cancer cells by targeted drug-carrying phage nanomedicines

I. Yacoby, H. Bar, I. Benhar, 2008, BMC biotechnology.

Targeting EGFR‐positive cancer cells with cetuximab–ZZ‐PE38: Results of in vitro and in vivo studies

R. Ben-yosef, I. Barnea, A. Vexler, 2013, Head & neck.

Antibody isolation from immunized animals: comparison of phage display and antibody discovery via V gene repertoire mining.

George Georgiou, Y. Wine, G. Georgiou, 2012, Protein engineering, design & selection : PEDS.

Selection of antibodies from synthetic antibody libraries.

I. Benhar, Itai Benhar, Noa Harel Inbar, 2012, Archives of biochemistry and biophysics.

Design of synthetic antibody libraries

I. Benhar, 2007, Expert opinion on biological therapy.

Escherichia coli maltose-binding protein as a molecular chaperone for recombinant intracellular cytoplasmic single-chain antibodies.

Y. Berdichevsky, H. Bach, D. Gutnick, 2001, Journal of molecular biology.

Phage display of a cellulose binding domain from Clostridium thermocellum and its application as a tool for antibody engineering.

R. Lamed, E. Ben-Zeev, I. Benhar, 1999, Journal of immunological methods.

A human synthetic combinatorial library of arrayable single-chain antibodies based on shuffling in vivo formed CDRs into general framework regions.

I. Benhar, Itai Benhar, Ronit Azriel-Rosenfeld, 2004, Journal of molecular biology.

Large scale production of recombinant antibodies by utilizing cellulose-binding domains.

Y. Berdichevsky, I. Benhar, 2003, Methods in molecular biology.

"Inclonals": IgGs and IgG-enzyme fusion proteins produced in an E. coli expression-refolding system.

I. Benhar, R. Hakim, 2009, mAbs.

Targeting Antibacterial Agents by Using Drug-Carrying Filamentous Bacteriophages

Iftach Yacoby, I. Yacoby, H. Bar, 2006, Antimicrobial Agents and Chemotherapy.

B cells engineered to express an anti-HIV antibody allow memory retention, class switch recombination and clonal selection in mice

D. Burstein, Y. Wine, I. Dotan, 2020, bioRxiv.

Characterization of B1(Fv)PE38 and B1(dsFv)PE38: single-chain and disulfide-stabilized Fv immunotoxins with increased activity that cause complete remissions of established human carcinoma xenografts in nude mice.

I. Pastan, I. Benhar, 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.

In vivo anti-MUC1+ tumor activity and sequences of high-affinity anti-MUC1-SEA antibodies

N. Smorodinsky, A. Meeker, C. Garbar, 2020, Cancer Immunology, Immunotherapy.

Recombinant single chain antibodies in bioelectrochemical sensors.

J. Rishpon, I. Benhar, S. Shaky, 2001, Talanta.

Administration of disulfide‐stabilized Fv‐immunotoxins B1(dsFv)‐PE38 and B3(dsFv)‐PE38 by continuous infusion increases their efficacy in curing large tumor xenografts in nude mice

I. Pastan, Y. Reiter, I. Benhar, 1995, International journal of cancer.

Melanoma Differentiation Antigen TCR-Like Specificity Directed Toward a Using a Recombinant Antibody with Selective Targeting of Melanoma and APCs

Avital Lev, Y. Reiter, I. Benhar, 2003 .

Selective Targeting of Melanoma and APCs Using a Recombinant Antibody with TCR-Like Specificity Directed Toward a Melanoma Differentiation Antigen 1

Avital Lev, Y. Reiter, I. Benhar, 2003, The Journal of Immunology.

Antibody-Based Immunotoxins for the Treatment of Cancer

N. Becker, I. Benhar, 2012 .

Challenges for Therapeutic Application of Pseudomonas Exotoxin-Based Immunotoxins

I. Benhar, V. Dergachev, 2015 .

MUC1/X Protein Immunization Enhances cDNA Immunization in Generating Anti-MUC1 α/β Junction Antibodies that Target Malignant Cells

D. Wreschner, I. Benhar, B. Katz, 2006 .

chFRP5-ZZ-PE38, a large IgG-toxin immunoconjugate outperforms the corresponding smaller FRP5(Fv)-ETA immunotoxin in eradicating ErbB2-expressing tumor xenografts.

W. Wels, R. Noy, I. Benhar, 2007, Cancer letters.

Cross-reactivity between annexin A2 and Beta-2-glycoprotein I in animal models of antiphospholipid syndrome

Y. Shoenfeld, M. Blank, I. Benhar, 2017, Immunologic research.

and BacteriophagesDrug-Carrying Filamentous Targeting Antibacterial Agents by Using

I. Yacoby, H. Bar, I. Benhar, 2006 .

Production of stabilized scFv antibody fragments in the E. coli bacterial cytoplasm.

I. Benhar, Lilach Vaks, 2014, Methods in molecular biology.

A modular platform for targeted RNAi therapeutics

J. Lieberman, D. Peer, M. Behlke, 2018, Nature Nanotechnology.

Cytotoxic and antitumor activity of a recombinant tumor necrosis factor-B1(Fv) fusion protein on LeY antigen-expressing human cancer cells.

U. Scherf, I. Pastan, U. Brinkmann, 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

Inhibition of protease-inhibitor-resistant hepatitis C virus replicons and infectious virus by intracellular intrabodies.

S. Lemon, Assaf Shapira, R. Jangra, 2010, Antiviral research.

The MUC1 oncoprotein as a functional target: Immunotoxin binding to α/β junction mediates cell killing

N. Smorodinsky, Ningping Feng, D. Wreschner, 2009, International journal of cancer.

Molecular Landscape of Anti-Drug Antibodies Reveals the Mechanism of the Immune Response Following Treatment With TNFα Antagonists

Y. Wine, U. Kopylov, S. Ben-Horin, 2019, Frontiers in immunology.

A procedure for amino acid sequencing in internal regions of proteins.

I. Benhar, H. Engelberg-Kulka, Itai Benhar, 1991, Gene.

Matrix-assisted refolding of single-chain Fv- cellulose binding domain fusion proteins.

D Frenkel, D. Frenkel, U. Gophna, 1999, Protein expression and purification.

A novel high throughput screening assay for HCV NS3 serine protease inhibitors.

Y. Berdichevsky, R. Koren, R. Tur-kaspa, 2003, Journal of virological methods.

Cell transformation induced by hepatitis C virus NS3 serine protease

Y. Berdichevsky, R. Tur-kaspa, A. Golan-Goldhirsh, 2001, Journal of viral hepatitis.

Autoantibodies to Annexin A2 and cerebral thrombosis: Insights from a mouse model

J. Chapman, N. Agmon-Levin, I. Benhar, 2021, Lupus.

Sustained secretion of anti‐tumor necrosis factor α monoclonal antibody from ex vivo genetically engineered dermal tissue demonstrates therapeutic activity in mouse model of rheumatoid arthritis

Shay Sherbo, Atar Liran, N. Shapir, 2017, The journal of gene medicine.

Engineered Toxins “Zymoxins” Are Activated by the HCV NS3 Protease by Removal of an Inhibitory Protein Domain

Assaf Shapira, R. Tur-kaspa, I. Benhar, 2011, PloS one.

Crystal structure of the catalytic domain of Pseudomonas exotoxin A complexed with a nicotinamide adenine dinucleotide analog: implications for the activation process and for ADP ribosylation.

I. Pastan, D. Davies, F. Dyda, 1996, Proceedings of the National Academy of Sciences of the United States of America.

A key role for IL-13 signaling via the type 2 IL-4 receptor in experimental atopic dermatitis

M. Rothenberg, A. Munitz, I. Benhar, 2020, Science Immunology.

Removal of Hepatitis C Virus-Infected Cells by a Zymogenized Bacterial Toxin

Assaf Shapira, R. Tur-kaspa, I. Benhar, 2012, PloS one.

Unravelling plasmidome distribution and interaction with its hosting microbiome.

E. Halperin, S. Sørensen, R. Shamir, 2019, Environmental microbiology.

Leukocyte-Specific siRNA Delivery Revealing IRF8 as a Potential Anti-Inflammatory Target.

E. Elinav, D. Peer, M. Behlke, 2019, Journal of controlled release : official journal of the Controlled Release Society.

Inhibition of hepatitis C virus NS3-mediated cell transformation by recombinant intracellular antibodies.

Y. Berdichevsky, R. Tur-kaspa, I. Benhar, 2004, Journal of hepatology.

Cross-immunogenicity: antibodies to infliximab in Remicade-treated patients with IBD similarly recognise the biosimilar Remsima

S. Ben-Horin, R. Eliakim, I. Benhar, 2015, Gut.

The isolation of novel phage display-derived human recombinant antibodies against CCR5, the major co-receptor of HIV.

Alon Herschhorn, A. Hizi, M. Kotler, 2013, Viral immunology.

Antibody Isolation From a Human Synthetic Combinatorial and Other Libraries of Single-Chain Antibodies.

I. Benhar, L. Nahary, A. Bitton, 2018, Methods in molecular biology.

An internalizing antibody specific for the human asialoglycoprotein receptor.

I. Benhar, Alla Trahtenherts, 2009, Hybridoma.

Design of a human synthetic combinatorial library of single-chain antibodies.

I. Benhar, L. Nahary, 2009, Methods in molecular biology.

Phage Display of Single‐Chain Antibody Constructs

Y. Reiter, I. Benhar, 2002, Current protocols in immunology.

Highly efficient selection of phage antibodies mediated by display of antigen as Lpp-OmpA' fusions on live bacteria.

I. Benhar, L. Nahary, S. Shaky, 2000, Journal of molecular biology.

Isolation of scFvs that inhibit the NS3 protease of hepatitis C virus by a combination of phage display and a bacterial genetic screen.

I. Benhar, L. Nahary, Alla Trahtenherts, 2009, Methods in molecular biology.

Design Principles for Bispecific IgGs, Opportunities and Pitfalls of Artificial Disulfide Bonds

I. Benhar, S. Shapira, Leeron Shefet-Carasso, 2018, Antibodies.

MUC1/X protein immunization enhances cDNA immunization in generating anti-MUC1 alpha/beta junction antibodies that target malignant cells.

D. Wreschner, I. Benhar, B. Katz, 2006, Cancer research.

Rapid humanization of the Fv of monoclonal antibody B3 by using framework exchange of the recombinant immunotoxin B3(Fv)-PE38.

I. Pastan, E. Padlan, S. Jung, 1994, Proceedings of the National Academy of Sciences of the United States of America.

Mutations of two lysine residues in the CDR loops of a recombinant immunotoxin that reduce its sensitivity to chemical derivatization.

I. Pastan, U. Brinkmann, I. Benhar, 1994, Bioconjugate chemistry.

Antibody-targeted drugs and drug resistance--challenges and solutions.

I. Benhar, Leeron Shefet-Carasso, 2015, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

Suppression of hepatitis C virus by the flavonoid quercetin is mediated by inhibition of NS3 protease activity

R. Tur-kaspa, I. Benhar, A. Shapira, 2012, Journal of viral hepatitis.

Novel Water-Soluble Amphotericin B-PEG Conjugates with Low Toxicity and Potent in Vivo Efficacy.

N. Osherov, I. Benhar, A. Szpilman, 2016, Journal of medicinal chemistry.

An investigation of antistreptococcal antibody responses in guttate psoriasis

I. Benhar, L. Nahary, L. Fry, 2008, Archives of Dermatological Research.

Insights into the bovine rumen plasmidome

Adi Doron-Faigenboim, Itzhak Mizrahi, Aya Brown Kav, 2012, Proceedings of the National Academy of Sciences.

Targeted Drug-Carrying Bacteriophages as Antibacterial Nanomedicines

Iftach Yacoby, I. Yacoby, H. Bar, 2007, Antimicrobial Agents and Chemotherapy.

A Simple and Rapid Method for Preparing a Cell-Free Bacterial Lysate for Protein Synthesis

Y. Shoham, A. Schroeder, I. Benhar, 2016, PloS one.

Risks and untoward toxicities of antibody-based immunoconjugates.

I. Benhar, Dana Litvak-Greenfeld, 2012, Advanced drug delivery reviews.

Immune checkpoint inhibitor combinations: Current efforts and important aspects for success.

I. Benhar, E. Kon, 2019, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

Toxin-Based Therapeutic Approaches

Assaf Shapira, I. Benhar, A. Shapira, 2010, Toxins.

Frameshifting in the Expression of the trpR Gene of EscherichiaColi

H. Engelberg-Kulka, I. Benhar, Chaya Miller, 1990 .

Inhibition of hepatitis C virus RNA replicons by peptide aptamers.

R. Tur-kaspa, I. Benhar, M. Gal-Tanamy, 2008, Antiviral research.

HCV NS3 serine protease-neutralizing single-chain antibodies isolated by a novel genetic screen.

Y. Berdichevsky, R. Tur-kaspa, I. Benhar, 2005, Journal of molecular biology.

Novel immune check point inhibiting antibodies in cancer therapy-Opportunities and challenges.

I. Benhar, Yael Diesendruck, 2017, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

Primate antibody response to immunotoxin: serological and computer-aided analysis of epitopes on a truncated form of Pseudomonas exotoxin

I. Pastan, S. Jung, B. Lee, 1994, Infection and immunity.

Combinatorial Libraries of Arrayable Single-Chain Antibodies

I. Benhar, 2009 .

Frameshifting in the expression of the Escherichia coli trpR gene

H. Engelberg-Kulka, I. Benhar, Chaya Miller, 1992, Molecular microbiology.

Successful intracranial delivery of trastuzumab by gene‐therapy for treatment of HER2‐positive breast cancer brain metastases

Shay Sherbo, Atar Liran, P. Ofek, 2018, Journal of controlled release : official journal of the Controlled Release Society.

Therapeutic Targeting of the Interleukin-4/Interleukin-13 Signaling Pathway: In Allergy and Beyond

A. Munitz, I. Benhar, D. Karo-Atar, 2018, BioDrugs.

Duality of serotonin-N-acetyltransferase in the gilthead seabream (Sparus aurata): molecular cloning and characterization of recombinant enzymes.

Y. Gothilf, I. Benhar, S. Coon, 2004, General and comparative endocrinology.

Insulin-degrading enzyme higher in subjects with metabolic syndrome

G. Shefer, D. Frenkel, N. Stern, 2021, Endocrine.

Antibody targeting of cell-bound MUC1 SEA domain kills tumor cells.

N. Smorodinsky, D. Wreschner, I. Benhar, 2012, Cancer research.

Annexin A2, autoimmunity, anxiety and depression.

J. Chapman, I. Benhar, L. Nahary, 2016, Journal of autoimmunity.

A novel magnetic beads-based method for polioviral concentration from environmental samples.

Y. Manor, E. Mendelson, Javier Martin, 2018, Journal of virological methods.

Colorectal Cancer Prevention

Izhak Haviv, I. Haviv, Liangping Li, 2017, The American Journal of Gastroenterology.

Engineered B cells expressing an anti-HIV antibody enable memory retention, isotype switching and clonal expansion

D. Burstein, Y. Wine, Y. Carmi, 2020, Nature Communications.

Disruption of P‐glycoprotein anticancer drug efflux activity by a small recombinant single‐chain Fv antibody fragment targeted to an extracellular epitope

Y. Assaraf, Y. Reiter, I. Benhar, 2004, International journal of cancer.

Behavioral and neural effects of intra-striatal infusion of anti-streptococcal antibodies in rats

D. Joel, D. Lotan, D. Frenkel, 2014, Brain, Behavior, and Immunity.

Behavioral, Pharmacological, and Immunological Abnormalities after Streptococcal Exposure: A Novel Rat Model of Sydenham Chorea and Related Neuropsychiatric Disorders

D. Joel, J. Leckman, C. Winter, 2012, Neuropsychopharmacology.

Frameshifting in the expression of the Escherichia coli trpR gene is modulated by translation initiation

I. Benhar, C. Miller, H. Engelberg-Kulka, 1993, Journal of bacteriology.

Cloning, expression and characterization of the Fv fragments of the anti-carbohydrate mAbs B1 and B5 as single-chain immunotoxins.

I. Pastan, I. Benhar, 1994, Protein engineering.

Identification and elimination of an immunodominant T-cell epitope in recombinant immunotoxins based on Pseudomonas exotoxin A

Ronit Mazor, Ira Pastan, I. Pastan, 2012, Proceedings of the National Academy of Sciences.

Reciprocal interactions between innate immune cells and astrocytes facilitate neuroinflammation and brain metastasis via lipocalin-2

James A. Hutchinson, S. Haferkamp, A. Kanner, 2023, Nature Cancer.

Maltose-Binding Protein Enhances Secretion of Recombinant Human Granzyme B Accompanied by In Vivo Processing of a Precursor MBP Fusion Protein

W. Wels, I. Benhar, R. Jabulowsky, 2010, PloS one.

Optimization of EGFR high positive cell isolation procedure by design of experiments methodology

N. Eliaz, O. Levi, I. Benhar, 2015, Cytometry. Part B, Clinical cytometry.

Antibody internalization studied using a novel IgG binding toxin fusion.

I. Barnea, I. Benhar, I. Keydar, 2007, Journal of immunological methods.

Targeted anti bacterial therapy.

I. Yacoby, I. Benhar, Iftach Yacoby, 2007, Infectious disorders drug targets.

Therapeutic Targeting of the Interleukin-4/Interleukin-13 Signaling Pathway: In Allergy and Beyond

A. Munitz, I. Benhar, D. Karo-Atar, 2018, BioDrugs.

A universal strategy for stable intracellular antibodies.

W. Wels, I. Benhar, Stephen Hyland, 2005, Journal of immunological methods.

Versatile protein microarray based on carbohydrate‐binding modules

Y. Berdichevsky, E. Bayer, R. Lamed, 2005, Proteomics.

Preventive and therapeutic vaccination with PAP-3, a novel human prostate cancer peptide, inhibits carcinoma development in HLA transgenic mice

Avital Lev, E. Vadai, Y. Reiter, 2006, Cancer Immunology, Immunotherapy.

Addressing the Immunogenicity of the Cargo and of the Targeting Antibodies with a Focus on Deimmunized Bacterial Toxins and on Antibody-Targeted Human Effector Proteins

I. Benhar, Y. Grinberg, 2017, Biomedicines.

Recombinant immunotoxin for cancer treatment with low immunogenicity by identification and silencing of human T-cell epitopes

D. Baker, I. Pastan, Byungkook Lee, 2014, Proceedings of the National Academy of Sciences.

Modulation of Alzheimer’s β-amyloid neurotoxicity by site-directed single-chain antibody

B. Solomon, D. Frenkel, I. Benhar, 2000, Journal of Neuroimmunology.

Peptide mimotopes recognized by antibodies cetuximab and matuzumab induce a functionally equivalent anti-EGFR immune response

J. Koch, N. Müller, W. Wels, 2010, Oncogene.

A method for purifying high quality and high yield plasmid DNA for metagenomic and deep sequencing approaches.

I. Mizrahi, I. Benhar, Aya Brown Kav, 2013, Journal of microbiological methods.

Minimum information about a protein affinity reagent (MIAPAR)

Henning Hermjakob, David Juncker, David E. Gloriam, 2010, Nature Biotechnology.

Biotechnological applications of phage and cell display.

I. Benhar, 2001, Biotechnology advances.

Molecular Landscape of Anti-Drug Antibodies Reveals the Mechanism of the Immune Response Following Treatment With TNFα Antagonists

Y. Wine, U. Kopylov, S. Ben-Horin, 2019, bioRxiv.

Crystal structure of the disulfide‐stabilized Fv fragment of anticancer antibody B1: Conformational influence of an engineered disulfide bond

I. Pastan, G. Gilliland, Byungkook Lee, 1998, Proteins: Structure, Function, and Bioinformatics.

Humanization and epitope mapping of the H23 anti-MUC1 monoclonal antibody reveals a dual epitope specificity.

I. Benhar, I. Keydar, Y. Mazor, 2005, Molecular immunology.

Frameshifting in the expression of the E. coli trpR gene occurs by the bypassing of a segment of its coding sequence

H. Engelberg-Kulka, I. Benhar, H. Engelberg‐Kulka, 1993, Cell.

Epithelial cell‐expressed type II IL‐4 receptor mediates eosinophilic esophagitis

Z. Halpern, M. Rothenberg, A. Munitz, 2022, Allergy.

Abstracts of the 16th Annual Meeting of The Israel Society for Neuroscience Eilat, Israel, November 25–27, 2007

Yonina C. Eldar, Karl J. Friston, Leslie G. Ungerleider, 2008, Neural plasticity.

TAR1, A Human Anti-p53 Single-Chain Antibody, Restores Tumor Suppressor Function to Mutant p53 Variants

S. Orgad, B. Solomon, I. Benhar, 2010, Journal of immunotherapy.

Antibacterial nanomedicine.

I. Benhar, Iftach Yacoby, 2008, Nanomedicine.

Magnetic isolation of particles suspended in synovial fluid for diagnostics of natural joint chondropathies.

Noam Eliaz, Kalia Mendel, David Hendel, 2010, Acta biomaterialia.

Synthetic Cells Synthesize Therapeutic Proteins inside Tumors

Assaf Zinger, A. Schroeder, I. Benhar, 2018, Advanced healthcare materials.

A two-state electronic antigen and an antibody selected to discriminate between these states.

U. Sivan, M. Dines, Y. Reiter, 2008, Nano letters.

Lipid nanoparticles-loaded with toxin mRNA represents a new strategy for the treatment of solid tumors

D. Peer, I. Benhar, G. Somu, 2023, Theranostics.

Targeted filamentous bacteriophages as therapeutic agents

I. Benhar, Iftach Yacoby, 2008, Expert opinion on drug delivery.

Mechanical properties of Bio-Ferrography isolated cancerous cells studied by atomic force microscopy.

N. Eliaz, O. Levi, I. Benhar, 2019, Journal of the mechanical behavior of biomedical materials.

Isolating epidermal growth factor receptor overexpressing carcinoma cells from human whole blood by bio‐ferrography

N. Eliaz, O. Levi, I. Benhar, 2015, Cytometry. Part B, Clinical cytometry.

The effect of hyaluronan injections into human knees on the number of bone and cartilage wear particles captured by bio-ferrography.

N. Eliaz, K. Hakshur, D. Segal, 2011, Acta biomaterialia.

Antibody-Mediated Inhibition of Insulin-Degrading Enzyme Improves Insulin Activity in a Diabetic Mouse Model

D. Frenkel, I. Benhar, L. Nahary, 2022, Frontiers in Immunology.

Abstracts of the 16th Annual Meeting of The Israel Society for Neuroscience Eilat, Israel, November 25–27, 2007

Yonina C. Eldar, Karl J. Friston, Leslie G. Ungerleider, 2008, Neural plasticity.

Early perceptual loss in depression

Yonina C. Eldar, Karl J. Friston, Charles R. Seger, 2007 .

The crystal structure of Pseudomonas aeruginosa exotoxin domain III with nicotinamide and AMP: conformational differences with the intact exotoxin.

I. Pastan, D. Davies, F. Dyda, 1995, Proceedings of the National Academy of Sciences of the United States of America.

Inhibition of Sema-3A Promotes Cell Migration, Axonal Growth, and Retinal Ganglion Cell Survival

A. Barzilai, A. Messeguer, M. Safrin, 2021, Translational vision science & technology.

Identification of Residues That Stabilize the Single-chain Fv of Monoclonal Antibodies B3 (*)

I. Pastan, I. Benhar, 1995, The Journal of Biological Chemistry.

Identification and characterization of a novel molecular-recognition and self-assembly domain within the islet amyloid polypeptide.

Sharon Gilead, Ehud Gazit, E. Gazit, 2002, Journal of molecular biology.

Antibody molecules discriminate between crystalline facets of a gallium arsenide semiconductor.

U. Sivan, Y. Reiter, I. Benhar, 2006, Nano letters.

On the limited recognition of inorganic surfaces by short peptides compared with antibodies

U. Sivan, H. Soifer, Y. Reiter, 2014, Journal of peptide science : an official publication of the European Peptide Society.

Fluorescent IgG fusion proteins made in E. coli

I. Benhar, Y. Luria, Dina Raichlin, 2012, mAbs.

Abstracts of the 15th Annual Meeting of the Israel Society for Neuroscience Eilat, Israel, December 3–5, 2006

Leslie G. Ungerleider, D. Amit, H. Seung, 2006, Neural Plasticity.

Universal Biofactor-Releasing Scaffold Enabling in Vivo Reloading.

T. Dvir, I. Benhar, Leeron Shefet Carasso, 2019, Nano letters.

Electrically controlled molecular recognition harnessed to activate a cellular response.

U. Sivan, Z. Eshhar, Y. Reiter, 2011, Nano letters.

Novel Water-Soluble Amphotericin B ‑ PEG Conjugates with Low Toxicity and Potent in Vivo E ﬃ cacy

N. Osherov, I. Benhar, A. Szpilman, 2016 .

In vivo characteristics of targeted drug-carrying filamentous bacteriophage nanomedicines

I. Benhar, Lilach Vaks, 2011, Journal of nanobiotechnology.

Bacteriophages transportant des medicaments cibles

E. Ron, I. Benhar, D. Shabat, 2006 .

Eosinophilic Esophagitis Is Critically Mediated By IL-13 Signaling Via IL13Ra1

M. Rothenberg, A. Munitz, C. Varol, 2022, Journal of Allergy and Clinical Immunology.

Diagnosis and Treatment of Paraneoplastic Neurologic Syndromes

I. Benhar, T. Böldicke, J. Rhee, 2023, Antibodies.

An immunoconjugate of anti-CD24 and Pseudomonas exotoxin selectively kills human colorectal tumors in mice.

N. Arber, I. Benhar, S. Kraus, 2011, Gastroenterology.

Translational introns: an additional regulatory element in gene expression.

H. Engelberg-Kulka, I. Benhar, R. Schoulaker-Schwarz, 1993, Trends in biochemical sciences.

"BIClonals": Production of Bispecific Antibodies in IgG Format in Transiently Transfected Mammalian Cells.

I. Benhar, L. Nahary, Lilach Vaks, 2018, Methods in molecular biology.

Behavioral and neural effects of intra-striatal infusion of anti-streptococcal antibodies in rats

D. Joel, D. Lotan, D. Frenkel, 2014, Brain, Behavior, and Immunity.

An immunoconjugate of anti-CD24 and Pseudomonas exotoxin selectively kills human colorectal tumors in mice.

N. Arber, I. Benhar, S. Kraus, 2011, Gastroenterology.

Pseudomonas exotoxin A mutants. Replacement of surface-exposed residues in domain III with cysteine residues that can be modified with polyethylene glycol in a site-specific manner.

I. Pastan, D. Fitzgerald, I. Benhar, 1994, Journal of Biological Chemistry.

Using Combination therapy to overcome diverse challenges of Immune Checkpoint Inhibitors treatment

I. Benhar, Racheli Birnboim-Perach, 2024, International journal of biological sciences.

Synthetic Cells Synthesize Therapeutic Proteins inside Tumors

Assaf Zinger, I. Benhar, N. Krinsky, 2018, Advanced healthcare materials.